N. Curry Et Al. , "Once-weekly prophylaxis with glycoPEGylated recombinant factor VIII (N8-GP) in severe haemophilia A: Safety and efficacy results from pathfinder 2 (randomized phase III trial)," HAEMOPHILIA , vol.25, no.3, pp.373-381, 2019
Curry, N. Et Al. 2019. Once-weekly prophylaxis with glycoPEGylated recombinant factor VIII (N8-GP) in severe haemophilia A: Safety and efficacy results from pathfinder 2 (randomized phase III trial). HAEMOPHILIA , vol.25, no.3 , 373-381.
Curry, N., Albayrak, C., Escobar, M., Holme, P. A., Kearney, S., Klamroth, R., ... Misgav, M.(2019). Once-weekly prophylaxis with glycoPEGylated recombinant factor VIII (N8-GP) in severe haemophilia A: Safety and efficacy results from pathfinder 2 (randomized phase III trial). HAEMOPHILIA , vol.25, no.3, 373-381.
Curry, Nicola Et Al. "Once-weekly prophylaxis with glycoPEGylated recombinant factor VIII (N8-GP) in severe haemophilia A: Safety and efficacy results from pathfinder 2 (randomized phase III trial)," HAEMOPHILIA , vol.25, no.3, 373-381, 2019
Curry, Nicola Et Al. "Once-weekly prophylaxis with glycoPEGylated recombinant factor VIII (N8-GP) in severe haemophilia A: Safety and efficacy results from pathfinder 2 (randomized phase III trial)." HAEMOPHILIA , vol.25, no.3, pp.373-381, 2019
Curry, N. Et Al. (2019) . "Once-weekly prophylaxis with glycoPEGylated recombinant factor VIII (N8-GP) in severe haemophilia A: Safety and efficacy results from pathfinder 2 (randomized phase III trial)." HAEMOPHILIA , vol.25, no.3, pp.373-381.
@article{article, author={Nicola Curry Et Al. }, title={Once-weekly prophylaxis with glycoPEGylated recombinant factor VIII (N8-GP) in severe haemophilia A: Safety and efficacy results from pathfinder 2 (randomized phase III trial)}, journal={HAEMOPHILIA}, year=2019, pages={373-381} }